Autologous Skin-Grafting Surgery to Prevent Esophageal Stenosis After Complete Circular Endoscopic Submucosal Tunnel Dissection for Superficial Esophageal Neoplasms.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 30882422.
- Also identified by DOI 10.14309/ajg.0000000000000169.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To assess the safety and effectiveness of autologous skin-grafting surgery (ASGS) for preventing esophageal stenosis after complete circular endoscopic submucosal tunnel dissection (ccESTD) for superficial esophageal neoplasms. Between October 2017 and March 2018, 8 patients who underwent ccESTD and ASGS were included. We assessed the occurrence of esophageal stenosis and adverse events. No adverse events occurred, including perforation, bleeding, wound infection, or stent migration. Five patients did not experience stenosis over a median follow-up of 7 months. ASGS appeared to be a safe and effective way to prevent esophageal stenosis after ccESTD.
Medical subject headings
- Carcinoma, Squamous Cell
- Endoscopic Mucosal Resection
- Esophageal Mucosa
- Esophageal Neoplasms
- Postoperative Complications
- Skin Transplantation